Agenda
What is immunotherapy, and how does it treat ALL?
- How different immunotherapies work, and why we use them for ALL
- Traditional treatment overview, and how immunotherapy fits into the treatment landscape
- Key differences between immunotherapy and chemotherapy
What immunotherapies are available for the treatment of ALL?
- Overview of approved and investigational immunotherapies for the treatment of ALL
- Which patients are eligible for immunotherapies, and when they are given in the treatment journey
Patient voice: Lived experience with immunotherapies, and insights for better patient care
- Patient presentation of their experience with immunotherapies in ALL, including patient journey, side effects, and what HCPs need to know
- Panel discussion featuring patient and HCP representation to discuss how to improve the patient experience with novel therapies, including immunotherapies
Closing remarks
- Key takeaways for patients
- Links to credible resources
- Q&A and post-webinar evaluation
Learning objectives
After attending this webinar, learners will be able to:
- Describe how immunotherapies work and why they are used in ALL.
- Identify which patients are eligible for immunotherapies in ALL.
- Recall the strategies to manage the adverse effects associated with immunotherapies in ALL.
- Recall the supportive care strategies for immunotherapies in ALL.
- Recall the strategies to increase effective patient–HCP communication.
Our speakers
Meet our panel of experts
Jaymz Goodman
Manchester, UK
Charles Mullighan
St. Jude Children's Research Hospital
Memphis, US
Wendy Stock
The University of Chicago
Chicago, US
Jessica Olson
California, US
About SES
Delivering streamlined independent medical education to enhance clinical practice. SES hubs allow time-stretched healthcare professionals to easily access curated scientific, medical, and clinical information that expedites their learning and empowers their treatment decisions. Informed by patients, curated by world leaders, and endorsed by expert societies, our hubs support healthcare professionals worldwide with up-to-date, accessible, and impactful educational content.
About Know ALL
Know ALL aspires to facilitate and improve acute lymphoblastic leukemia knowledge worldwide and develop community-based initiatives to overcome current and future challenges.
The mission of Know ALL is to drive awareness of acute lymphoblastic leukemia globally through community collaborations, while continuing to raise awareness of the resources and support currently available.